CXCR4 is overexpressed in a variety of malignancies, including breast, pancreas, thyroid, prostate, kidney, lung, and brain cancers, contributing to tumor growth, angiogenesis, tumor microenvironment interactions, metastasis, and therapeutic resistance [17, 18]. The gene discussed is CXCR4; the disease is neoplasm.